Search

Introduction: Gynecological cancers are among the most common in women worldwide, with cervical cancer (CC) being the most frequent type and considered an important public health problem. Methodology: This is a descriptive, cross-sectional, observational study with a quantitative approach, in which 76 women who were being treated for CC in 2020 were interviewed through a questionnaire. The data were entered and reviewed in a program spreadsheet editor and analyzed in a statistical program, where the absolute and relative frequencies of the variables of interest were calculated. Results: It was observed that 27.6% of the women were between 41 and 50 years old, 72.4% were brown, 35.5% had not completed elementary school, 53.9% were married or in a stable relationship, 43.4% had a paid job and 56.6% had a monthly family income of one minimum wage, with 38.2% having menarche at the age of 12 years or less, 65.8% reported their first sexual intercourse at 16 or more years of age, 48.7% had five or more pregnancies, 55.3% had no history of miscarriage, 64.5% used or are using hormonal contraceptives, 60.5% did not undergo regular Pap smear tests and 58.82% had a diagnosis of CC at an advanced stage. Conclusion: Socioeconomic vulnerability, early onset of sexual life, multiparity, low adherence to the preventive examination and diagnosis at na advanced stage were the main characteristics of patients affected by CC.

On March 11, 2020, the World Health Organization declared the new Coronavirus a pandemic, due to the large number of cases and deaths worldwide. The upper inhalation routes are the gateway for any viral variant, with the installation of SAR-CoV-2 in the respiratory epithelium, which, belonging to the Coronovidae family, has an acidic pH. Alkalization is a way to destabilize the pathophysiology of COVID-19. In this way, the introduction of saline solutions into the upper respiratory system would be a way of interfering with the symptomatology and behavior of the virus. Objective: To evaluate the role of inhaled 3% sodium bicarbonate solution in improving respiratory symptoms and destabilizing SAR-CoV-2 in COVID-19. Materials and methods: Randomized clinical trial, with people diagnosed with COVID-19 through the RT-PCR assay. The participants included were of any age and gender undergoing hospital treatment at the COVID-19 ward unit at the Hospital Regional Doutor Estácio Muniz, located in the municipality of Aquidauana in the State of Mato Grosso do Sul, between September/2020 and November/2021. Results: It was observed that moderate/severe patients who received inhaled treatment with a 3% sodium bicarbonate solution had a good prognosis for their respiratory condition, progressing to hospital discharge. Conclusion: Treatment with sodium bicarbonate solution has a high potential in the treatment as an adjunct to COVID-19.

Introduction: This study aimed to evaluate the use of sodium bicarbonate solution as an adjunct in the treatment of pediatric patients with moderate symptoms through nebulization. Methods: Two matched groups were followed, of which 2 received treatment with sodium bicarbonate solution along with conventional treatment and 2 patients used saline solution plus conventional treatment. Results: Pulmonary auscultation was better in snoring and crackles in patients treated with sodium bicarbonate solution compared to patients treated with saline. Radiological findings, decreased opacity and bilateral consolidations, as well as reduced length of hospital stay (increase) were observed in patients treated with sodium bicarbonate solution. Conclusion: The use of sodium bicarbonate solution as an adjunct in the treatment of COVID-19 improved the prognosis compared to conventional treatment in pediatric patients.